EDAP TMS (EDAP) has taken a significant step toward expanding its AI-assisted prostate cancer care through a strategic collaboration with AI healthcare company Avenda Health. This partnership is centered around integrating Avenda's FDA-cleared Unfold AI technology into EDAP's Focal One robotic high-intensity focused ultrasound (HIFU) platform. This is expected to create the world's first AI-assisted Focal One HIFU procedures. EDAP Stock Movement Since the announcement on Sept. 19, EDAP shares have remained ...